Pearl Steinzor

April Armstrong, MD, MPH, chief of dermatology, UCLA, discusses clinical trial findings from the phase 2b study on zasocitinib.

Findings from a new study reveal significant racial differences in skin biopsy frequency for psoriasis diagnosis, indicating potential diagnostic challenges, particularly for Black patients.

The US health care system is underperforming despite high spending, and reform is needed in areas like insurance coverage, primary care, and equity to improve overall health outcomes and efficiency.

The FDA approved benralizumab (Fasenra) for adult patients with eosinophilic granulomatosis with polyangiitis (EGPA).

Patients seeking free preventive care continue to face cost-sharing and administrative hurdles, a study reveals.

Respiratory syncytial virus (RSV) vaccination in adults aged 60 years and older may be cost-effective in preventing illness, hospitalizations, lost quality of life, and deaths, according to one study.

Toby Maher, MD, PhD, professor of clinical medicine, Keck Medicine of USC, discusses recent advancements in clinical trials for patients with idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF).

Speakers at the 2024 meeting of ERS—The European Respiratory Society Congress share their favorite parts of the conference.

Breakthrough research identifies TIM3 as a key target in MAPK-activated pediatric gliomas, offering new hope for more effective immunotherapy treatments.

Klaus Rabe, MD, PhD, chest physician and professor of medicine, University of Kiel, shares the latest clinical discoveries from the BOREAS trial on type 2 inflammation in patients with chronic obstructive pulmonary disease (COPD).

Eva Otter, president of Pulmonary Hypertension Association Europe, discusses the significance of shared decision-making for patients with pulmonary arterial hypertension.

Alexander Mathioudakis, MD, PhD, clinical lecturer in respiratory medicine at The University of Manchester, shares findings from the FLAME trial on blood eosinophil changes in patients with chronic obstructive pulmonary disorder.

Wanda Phipatanakul, MD, MS, professor of pediatrics at Harvard Medical School and director of the Clinical Research Center at Boston Children's Hospital, discusses some of the most significant health disparities impacting respiratory care.

Io Hui, PhD, researcher at The University of Edinburgh, discusses how artificial intelligence (AI) is being applied in respiratory care for both clinicians and patients.

There are general risk factors for patients with rheumatic disease developing interstitial lung disease, but there are also disease-specific risk factors depending on which rheumatic disease they have, explained Anna-Maria Hoffmann-Vold, MD, PhD, a senior consultant and leader of inflammatory and fibrotic research area at Oslo University Hospital.

According to some reports, the draft rule imposes strict limitations on telehealth prescriptions even as advocates push for extension of current flexibilities.

Martin Kolb, MD, PhD, professor of medicine at McMaster University, previews key topics to be presented at this year's European Respiratory Society (ERS) Congress.

The final report unveils actionable steps for integrating equity into health technology assessment.

The first real-world study highlights benefits for adults aged 60 years and older who receive the respiratory syncytial virus (RSV) vaccine.

Joseph Biggio, MD, system chair and service line leader for women's services and system chair for maternal fetal medicine at Ochsner Health, discusses some of the innovations to manage hypertension during pregnancy and postpartum.

Patients with cancer who forego surgery have higher suicide incidence than those who undergo treatment, a study finds.

A new survey highlights lack of awareness about respiratory syncytial virus (RSV) among older adults, posing increased health risks for those with chronic conditions.

Researchers examined the impact of baricitinib withdrawal and retreatment on hair regrowth in patients with severe alopecia areata.

An 18% reduction in acute care encounters for respiratory tract infections among infants 8 weeks or younger was identified following the implementation of New York's paid family leave policy.

A phase 2b clinical trial demonstrates the potential of zasocitinib in achieving biologic-level efficacy with minimal adverse effects.

The closures highlight financial challenges that rural hospitals face amid workforce shortages, rising costs, and leveling reimbursement.

Katherine Coerver, MD, PhD, FAAN, neurologist, Rocky Mountain Neurology, shares insights on advancements and challenges in neurological care.

Thyme Care welcomes its new senior vice president to lead initiatives in value-based oncology care.

Social vulnerability and economic disadvantages exacerbate financial hardship in cancer survivors, according to one study.

Spotty vaccine supplies have consumers searching for protection as the FDA prepares to approve updated COVID-19 shots.